Diamyd Medical's registrational Phase 3 trial in type 1 diabetes, has now exceeded 290, and the screening will conclude in the coming weeks. The interim ...
() - A clash of future visions that seems to encapsulate both the fears and hopes of many Pennsylvanians found expression at the Capitol this week.